Prognostic indicators in node-negative advanced gastric cancer patients

Journal of Surgical Oncology

Volumn 101, Issue 7, 2010, Pages 622-625

  Saito, Hiroaki ^a   Kuroda, Hirohiko ^a   Matsunaga, Tomoyuki ^a   Fukuda, Kenji ^a   Tatebe, Shigeru ^a   Tsujitani, Shunichi ^a   Ikeguchi, Masahide ^a  

^a TOTTORI UNIVERSITY   (Japan)

Author keywords

Gastric cancer; Lymph node metastasis; Prognosis; Tumor size

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER INVASION; CANCER PATIENT; FEMALE; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SEROSA; STOMACH ADENOCARCINOMA; SURVIVAL RATE; TUMOR VOLUME;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CHEMOTHERAPY, ADJUVANT; FEMALE; FOLLOW-UP STUDIES; GASTRECTOMY; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; STOMACH NEOPLASMS; SURVIVAL ANALYSIS;

EID: 77952036646     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21562     Document Type: Article

References (17)

1. Siewert JR, Bottcher K, Stein HJ, et al.: Relevant prognostic factors in gastric cancer: Ten-year results of the German Gastric Cancer Study. Ann Surg 1998;228:449-461.
2. Bozzetti F, Bonfanti G, Morabito A, et al.: A multifactorial approach for the prognosis of patients with carcinoma of the stomach after curative resection. Surg Gynecol Obstet 1986;162:229-234.
3. Kim JP, Kim YW, Yang HK, et al.: Significant prognostic factors by multivariate analysis of 3926 gastric cancer patients. World J Surg 1994;18:872-877, discussion 877-878.
4. Baba H, Maehara Y, Takeuchi H, et al.: Effect of lymph node dissection on the prognosis in patients with node-negative early gastric cancer. Surgery 1995;117:165-169.
5. Adachi Y, Mori M, Maehara Y, et al.: Prognostic factors of node-negative gastric carcinoma: Univariate and multivariate analyses. J Am Coll Surg 1997;184:373-377.
6. Maehara Y, Tomoda M, Tomisaki S, et al.: Surgical treatment and outcome for node-negative gastric cancer. Surgery 1997;121:633-639.
7. Bruno L, Nesi G, Montinaro F, et al.: Clinicopathologic characteristics and outcome indicators in node-negative gastric cancer. J Surg Oncol 2000;74:30-32.
8. Hyung WJ, Lee JH, Choi SH, et al.: Prognostic impact of lymphatic and/or blood vessel invasion in patients with node-negative advanced gastric cancer. Ann Surg Oncol 2002;9:562-567.
9. Joypaul BV, Hopwood D, Newman EL, et al.: The prognostic significance of the accumulation of p53 tumour-suppressor gene protein in gastric adenocarcinoma. Br J Cancer 1994;69:943-946.
10. Gomyo Y, Ikeda M, Osaki M, et al.: Expression of p21 (waf1/cip1/sdi1), but not p53 protein, is a factor in the survival of patients with advanced gastric carcinoma. Cancer 1997;79:2067-2072.
11. Mori M, Kakeji Y, Adachi Y, et al.: The prognostic significance of proliferating cell nuclear antigen in clinical gastric cancer. Surgery 1993;113:683-690.
12. Shino Y, Watanabe A, Yamada Y, et al.: Clinicopathologic evaluation of immunohistochemical E-cadherin expression in human gastric carcinomas. Cancer 1995;76:2193-2201.
13. Katano M, Nakamura M, Fujimoto K, et al.: Prognostic value of platelet-derived growth factor-A (PDGF-A) in gastric carcinoma. Ann Surg 1998;227:365-371.
14. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma - 2nd English Edition. Gastric Cancer 1998;1:10-24.
15. Saito H, Osaki T, Murakami D, et al.: Macroscopic tumor size as a simple prognostic indicator in patients with gastric cancer. Am J Surg 2006;192:296-300.
16. Kim DY, Seo KW, Joo JK, et al.: Prognostic factors in patients with node-negative gastric carcinoma: A comparison with node-positive gastric carcinoma. World J Gastroenterol 2006;12:1182-1186.
17. Kooby DA, Suriawinata A, Klimstra DS, et al.: Biologic predictors of survival in node-negative gastric cancer. Ann Surg 2003;237:828-835, discussion 835-1827